Lighthouse Investment Partners’s AstraZeneca AZN Stock Holding History

Lighthouse Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Sell	7,381 -11,954	-62%	-$2.25M	0.04%	425
2026 Q1	$3.81M	Buy	+19,335	New	+$3.73M	0.13%	234
2025 Q4	–	Sell	-12,500	Closed	-$1.92M	–	889
2025 Q3	$1.92M	Sell	12,500 -6,500	-34%	-$984K	0.06%	343
2025 Q2	$2.66M	Buy	19,000 +6,500	+52%	+$911K	0.1%	262
2025 Q1	$1.84M	Buy	+12,500	New	+$1.81M	0.08%	271
2024 Q4	–	Sell	-2,500	Closed	-$390K	–	496
2024 Q3	$390K	Sell	2,500 -29,331	-92%	-$4.73M	0.01%	390
2024 Q2	$4.96M	Buy	+31,831	New	+$4.79M	0.2%	134
2024 Q1	–	Sell	-3,127	Closed	-$414K	–	379
2023 Q4	$421K	Buy	+3,127	New	+$407K	0.02%	260

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lighthouse Investment Partners's AZN Position: Q2 2026 in Review

Lighthouse Investment Partners reduced its AstraZeneca (AZN) stake by 62% in Q2 2026, selling an estimated $2.25M and leaving 7,381 shares worth $1.4M. The position accounts for 0.04% of the portfolio, ranked #425.

Lighthouse Investment Partners first reported a position in AZN in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.96M in Q2 2024. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Lighthouse Investment Partners held 7,381 shares of AstraZeneca worth $1.4M as of Q2 2026.
Lighthouse Investment Partners sold 11,954 AstraZeneca shares in Q2 2026, an estimated $2.25M.
AstraZeneca made up 0.04% of Lighthouse Investment Partners's portfolio in Q2 2026, its #425 holding.
Lighthouse Investment Partners first reported a position in AstraZeneca in Q4 2023 and has held it in 8 quarters since.
Lighthouse Investment Partners's AstraZeneca position peaked at $4.96M in Q2 2024.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.